David Ewing DuncanCEO, Arc Fusion
David Ewing Duncan is an award-winning, best-selling author of nine books published in 21 languages. David is CEO and curator of Arc Fusion and a health strategist-in-residence for IDEO. He is a columnist for the Daily Beast and the chief correspondent for NPR Talk's Biotech Nation.
David writes for the New York Times, the Atlantic, Fortune, National Geographic, Outside, and many others. He is a former contributing editor to Wired, Discover, Technology Review, and Conde Nast Portfolio. He is a former commentator and special correspondent for NPR's Morning Edition, a special correspondent and producer for ABC's Nightline and 20/20, a former producer for Discovery Channel, and a former correspondent for NOVA's ScienceNow! .
His latest book is When I'm 164: The New Science of Radical Life Extension, and What Happens If It Succeeds (Ted books). He also wrote Experimental Man: What One Man's Body Reveals about His Future, Your Health, and Our Toxic World (Wiley). He is the founding director of the Center of Life Science Policy at UC Berkeley.
David is finishing his first novel, a biomedical thriller. David's work has won numerous awards, including Magazine Story of the Year from AAAS, and nominations for two National Magazine Awards. He serves on a special communications committee at the National Academies of Science and is on the faculty of Singularity University. David lives in San Francisco and is a member of the SF Writer's Grotto.